Evaluation of pitolisant, sodium oxybate, solriamfetol, and modafinil for the management of narcolepsy: a retrospective analysis of the FAERS database

Evaluation of pitolisant, sodium oxybate, solriamfetol, and modafinil for the management of narcolepsy: a retrospective analysis of the FAERS database

ObjectiveNarcolepsy, a rare neurological disorder believed to have an autoimmune etiology, necessitates lifelong management. This study aimed to provide evidence supporting the safety of pharmacological treatment for narcolepsy.MethodsFive-year data on pitolisant, sodium oxybate, solriamfetol, and m...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaodan Zhou, Jia Chen, Bangtian Xu, Li Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Pharmacology
Subjects:	narcolepsy pitolisant sodium oxybate solriamfetol modafinil FAERS
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1415918/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Understanding the Patient Experience with Twice-Nightly Sodium Oxybate Therapy for Narcolepsy: A Social Listening Experiment
by: Maria Picone, et al.
Published: (2024-11-01)

How once-nightly sodium oxybate is processed in the body in healthy volunteers: a plain language summary
by: Richard Bogan, et al.
Published: (2025-03-01)

Green spectrofluorimetric method for quantification of sodium oxybate in pharmaceutical and plasma samples
by: Reem M. Alnemari, et al.
Published: (2025-07-01)

RESTORE: Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates
by: Asim Roy, et al.
Published: (2024-12-01)

Narcolepsy treatment: from exorcism and bloodletting to modern therapy with histamine receptor inverse agonists
by: E. Sakalauskaitė-Juodeikienė, et al.
Published: (2020-09-01)

Case Report: Narcolepsy patients masked behind obstructive sleep apnea syndrome (OSAS): report of 2 cases and literature review
by: Simin Zou, et al.
Published: (2025-04-01)

A Patient-centric Clinical Trial Design to Comprehensively Evaluate Low-Sodium Oxybate in People with Idiopathic Hypersomnia or Narcolepsy
by: Deborah A. Nichols, et al.
Published: (2025-06-01)

Armodafinil and modafinil in the treatment of cancer-related fatigue: A systematic review
by: Alexa Mcguinness
Published: (2025-07-01)

Modafinil alters the functional connectivity of distinct thalamic nuclei with the neocortex
by: Stefano Delli Pizzi, et al.
Published: (2025-05-01)

Diagnostic challenge of an untypical cutaneous drug reaction from modafinil
by: Rauno J. Harvima, et al.
Published: (2024-09-01)

Microwave coprocessing of modafinil with Gelucire®: Thermal and compression characteristics
by: Derar Omari, et al.
Published: (2025-01-01)

Pentylenetetrazol-induced seizures and brain neuroinflammation markers under conditions of pitolisant and pioglitazone use
by: O. Yehorenko, et al.
Published: (2025-04-01)

Acute hypobaric hypoxia attenuates the anti-fatigue effects of pitolisant by downregulating the expression of organic cation transporter 1 and P-glycoprotein
by: Gang Zhao, et al.
Published: (2025-04-01)

Evaluation of the effect of Modafinil in the improvement of the level of consciousness in patients with COVID‐19 encephalopathy: A randomized controlled trial
by: Fatemeh Talebi Kiasari, et al.
Published: (2024-09-01)

Global estimates of vaccine-associated narcolepsy from 1967 to 2023
by: Yi Deun Jeong, et al.
Published: (2025-07-01)

Utilizing quality by design methodology for liquid chromatography method development and validation in quantifying impurities in Pitolisant, a Histamine-3 (H3) receptor antagonist/inverse agonist
by: Jayaprakash Kanijam Raghupathi, et al.
Published: (2025-07-01)

Hypocretin neurotransmitter system and narcolepsy
by: Lakočević Milan B., et al.
Published: (2008-01-01)

Orexin system and pathogenesis of sleep-wake cycle disturbances in narcolepsy
by: Yu. V. Gavrilov, et al.
Published: (2018-01-01)

Narcolepsy: a case report and review of literature
by: E. Baltakytė, et al.
Published: (2019-12-01)

Treatment of idiopathic hypersomnia with modafinil in an individual at clinical high risk for psychosis: A case report
by: Yutaro Sato, et al.
Published: (2025-06-01)

Narcolepsy in early childhood: a case report and a Mini review
by: Guorui Liu, et al.
Published: (2025-01-01)

Issues related to differential diagnosis of epilepsy and narcolepsy
by: E. A. Kantimirova, et al.
Published: (2025-01-01)

Impaired Vigilance in Patients with Narcolepsy Type 1: A Psychomotor Vigilance Task Study
by: Yu J, et al.
Published: (2024-12-01)

Narcolepsy: a machine learning bibliometric analysis (1996–2024)
by: Minheng Zhang, et al.
Published: (2025-06-01)

Narcolepsy: an interface among neurology, immunology, sleep, and genetics
by: Fernando Morgadinho Santos Coelho
Published: (2024-06-01)

Integrative evidence linking excessive daytime sleepiness, narcolepsy, and hypertension: insights from NHANES, Mendelian randomization, and proteomics
by: Shenghui Feng, et al.
Published: (2025-07-01)

Correction: Narcolepsy: a machine learning bibliometric analysis (1996–2024)
by: Minheng Zhang, et al.
Published: (2025-07-01)

Case report: early onset narcolepsy initially misdiagnosed as obstructive sleep apnea syndrome
by: Mahmut Almbaidheen, et al.
Published: (2021-04-01)

Narcolepsy genetic variants associated with sleep efficiency in a community dwelling older cohort
by: Steven Jervis, et al.
Published: (2025-04-01)

Health-related quality of life in patients with narcolepsy types 1 and 2 from a Sleep Center in Brazil
by: Renata Carvalho CREMASCHI, et al.
Published: (2020-06-01)

Functional Brain Activity Alterations in Type 1 Narcolepsy Patients with Anxiety and Depression: A 7-Tesla Resting State-Functional Magnetic Resonance Imaging Study
by: Chen Y, et al.
Published: (2025-06-01)

Narcolepsy Is Associated With Subclinical Cardiovascular Disease as Early as Childhood: A Big Data Analysis
by: Christopher N. Kaufmann, et al.
Published: (2025-06-01)

Healthcare Burden and Productivity Loss Due to Narcolepsy in Sweden
by: Anna Giertz, et al.
Published: (2025-02-01)

Disproportionality analysis of oesophageal toxicity associated with oral bisphosphonates using the FAERS database (2004–2023)
by: Lin Chen, et al.
Published: (2024-11-01)

Analysis and mining of L-ornithine L-aspartate adverse events based on FAERS database
by: Hui Zhang, et al.
Published: (2025-07-01)

Drug-induced second tumors: a disproportionality analysis of the FAERS database
by: Shupeng Chen, et al.
Published: (2025-05-01)

Safety assessment of temozolomidee: real-world adverse event analysis from the FAERS database
by: Yu Liu, et al.
Published: (2025-08-01)

Disproportionality analysis of adverse events associated with ipilimumab and nivolumab combination therapy based on FAERS database
by: Xianyu Dai, et al.
Published: (2025-07-01)

Analysis and comparison of adverse events of colistin administered by different routes based on the FAERS database
by: Pengtao Xu, et al.
Published: (2025-03-01)

A real-world pharmacovigilance analysis of omadacycline in FDA adverse event reporting system (FAERS) database
by: Xueping Shi, et al.
Published: (2025-04-01)